Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Эндометриоидная аденокарцинома при беременности: клинический случай
Эндометриоидная аденокарцинома при беременности: клинический случай
Мусина Е.В., Траль Т.Г., Тарасова М.А. Эндометриоидная аденокарцинома при беременности: клинический случай. Гинекология. 2016; 18 (2): 81–83.
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Злокачественные опухоли при беременности встречаются в 0,07–0,1% случаев от числа всех беременностей. Эндометриоидная аденокрацинома является крайне редкой патологией при беременности. Однако существует актуальность онкологической настороженности в отношении эндометриоидной аденокарциномы у женщин репродуктивного возраста, в том числе на фоне беременности.
Ключевые слова: эндометриоидная аденокарцинома, беременность.
Key words: endometrioid adenocarcinoma, pregnancy.
Ключевые слова: эндометриоидная аденокарцинома, беременность.
________________________________________________
Key words: endometrioid adenocarcinoma, pregnancy.
Полный текст
Список литературы
1. Mitamura T, Watari H, Todo Y et al. A 14-year-old female patient with FIGO stage IB endometrial carcinoma: a case report. Int J Gynecol Cancer 2009; 19: 896–7.
2. Gusberg SB. Estrogen and endometrial cancer: an epilogue la recherche du temps perdu. Gynecol Oncol 1994; 52: 3–9.
3. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27: 1327–31.
4. Gottschau M et al. Risk of cancer among women with polycystic ovary syndrome. Gynecol Oncol 2015; 136: 99–103.
5. Gregory CW et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clinl Endocrinol Metab 2002; 87 (6): 2960–6.
6. Maliqueo M et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003; 80 (2): 812–9.
7. Quezada S et al. Evalution of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometrial from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85 (4): 1017–26.
8. Villavicencio A et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovary syndrome with and without endometrial hyperplasia. Gynecol Obstet 2006; 103 (1): 307–14.
9. Avellaira C et al. Expression of molecules associated with tissue homeostasis in secretory endometrial from untreated women with polycystic ovary syndrome. Hum Reprod 2006; 21 (12): 311–21.
10. Chen Y et al. Expression of apoptosis regulatoryprotein bcl-2 and bax in endometrium of polycystic ovary syndrome. Chinese J Obstet Gynecol 1999; 34 (11): 652–4.
11. Xin Li et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014; 21 (1): 2.
12. Завалишина Л.Э., Франк Г.А., Андреева Ю.Ю. Уточняющая диагностика при раках некоторых локализаций с использованием иммуногистохимических маркеров. Практич. пособие. М., 2006. / Zavalishina L.E., Frank G.A., Andreeva Iu.Iu. Utochniaiushchaia diagnostika pri rakakh nekotorykh lokalizatsii s ispol'zovaniem immunogistokhimicheskikh markerov. Praktich. posobie. M., 2006. [in Russian]
13. Киселев В.И., Ляшеко А.А. Молекулярные механизмы регуляции гиперпластических процессов. М.: Димитрейд График Групп, 2005. / Kiselev V.I., Liasheko A.A. Molekuliarnye mekhanizmy reguliatsii giperplasticheskikh protsessov. M.: Dimitreid Grafik Grupp, 2005. [in Russian]
14. Пальцев М.А., Иванов А.А. Межклеточные взаимодействия. М.: Медицина, 1995. / Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviia. M.: Meditsina, 1995. [in Russian]
15. Биохимические основы патологических процессов. Под ред. Е.С.Северина. М.: Медицина, 2000. / Biokhimicheskie osnovy patologicheskikh protsessov. Pod red. E.S.Severina. M.: Meditsina, 2000. [in Russian]
16. Табакман Ю.Ю. Рак эндометрия. Руководство для врачей. М.: Практическая медицина, 2009. / Tabakman Iu.Iu. Rak endometriia. Rukovodstvo dlia vrachei. M.: Prakticheskaia meditsina, 2009. [in Russian]
17. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
2. Gusberg SB. Estrogen and endometrial cancer: an epilogue la recherche du temps perdu. Gynecol Oncol 1994; 52: 3–9.
3. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27: 1327–31.
4. Gottschau M et al. Risk of cancer among women with polycystic ovary syndrome. Gynecol Oncol 2015; 136: 99–103.
5. Gregory CW et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clinl Endocrinol Metab 2002; 87 (6): 2960–6.
6. Maliqueo M et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003; 80 (2): 812–9.
7. Quezada S et al. Evalution of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometrial from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85 (4): 1017–26.
8. Villavicencio A et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovary syndrome with and without endometrial hyperplasia. Gynecol Obstet 2006; 103 (1): 307–14.
9. Avellaira C et al. Expression of molecules associated with tissue homeostasis in secretory endometrial from untreated women with polycystic ovary syndrome. Hum Reprod 2006; 21 (12): 311–21.
10. Chen Y et al. Expression of apoptosis regulatoryprotein bcl-2 and bax in endometrium of polycystic ovary syndrome. Chinese J Obstet Gynecol 1999; 34 (11): 652–4.
11. Xin Li et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014; 21 (1): 2.
12. Zavalishina L.E., Frank G.A., Andreeva Iu.Iu. Utochniaiushchaia diagnostika pri rakakh nekotorykh lokalizatsii s ispol'zovaniem immunogistokhimicheskikh markerov. Praktich. posobie. M., 2006. [in Russian]
13. Kiselev V.I., Liasheko A.A. Molekuliarnye mekhanizmy reguliatsii giperplasticheskikh protsessov. M.: Dimitreid Grafik Grupp, 2005. [in Russian]
14. Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviia. M.: Meditsina, 1995. [in Russian]
15. Biokhimicheskie osnovy patologicheskikh protsessov. Pod red. E.S.Severina. M.: Meditsina, 2000. [in Russian]
16. Tabakman Iu.Iu. Rak endometriia. Rukovodstvo dlia vrachei. M.: Prakticheskaia meditsina, 2009. [in Russian]
17. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
2. Gusberg SB. Estrogen and endometrial cancer: an epilogue la recherche du temps perdu. Gynecol Oncol 1994; 52: 3–9.
3. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27: 1327–31.
4. Gottschau M et al. Risk of cancer among women with polycystic ovary syndrome. Gynecol Oncol 2015; 136: 99–103.
5. Gregory CW et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clinl Endocrinol Metab 2002; 87 (6): 2960–6.
6. Maliqueo M et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003; 80 (2): 812–9.
7. Quezada S et al. Evalution of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometrial from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85 (4): 1017–26.
8. Villavicencio A et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovary syndrome with and without endometrial hyperplasia. Gynecol Obstet 2006; 103 (1): 307–14.
9. Avellaira C et al. Expression of molecules associated with tissue homeostasis in secretory endometrial from untreated women with polycystic ovary syndrome. Hum Reprod 2006; 21 (12): 311–21.
10. Chen Y et al. Expression of apoptosis regulatoryprotein bcl-2 and bax in endometrium of polycystic ovary syndrome. Chinese J Obstet Gynecol 1999; 34 (11): 652–4.
11. Xin Li et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014; 21 (1): 2.
12. Завалишина Л.Э., Франк Г.А., Андреева Ю.Ю. Уточняющая диагностика при раках некоторых локализаций с использованием иммуногистохимических маркеров. Практич. пособие. М., 2006. / Zavalishina L.E., Frank G.A., Andreeva Iu.Iu. Utochniaiushchaia diagnostika pri rakakh nekotorykh lokalizatsii s ispol'zovaniem immunogistokhimicheskikh markerov. Praktich. posobie. M., 2006. [in Russian]
13. Киселев В.И., Ляшеко А.А. Молекулярные механизмы регуляции гиперпластических процессов. М.: Димитрейд График Групп, 2005. / Kiselev V.I., Liasheko A.A. Molekuliarnye mekhanizmy reguliatsii giperplasticheskikh protsessov. M.: Dimitreid Grafik Grupp, 2005. [in Russian]
14. Пальцев М.А., Иванов А.А. Межклеточные взаимодействия. М.: Медицина, 1995. / Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviia. M.: Meditsina, 1995. [in Russian]
15. Биохимические основы патологических процессов. Под ред. Е.С.Северина. М.: Медицина, 2000. / Biokhimicheskie osnovy patologicheskikh protsessov. Pod red. E.S.Severina. M.: Meditsina, 2000. [in Russian]
16. Табакман Ю.Ю. Рак эндометрия. Руководство для врачей. М.: Практическая медицина, 2009. / Tabakman Iu.Iu. Rak endometriia. Rukovodstvo dlia vrachei. M.: Prakticheskaia meditsina, 2009. [in Russian]
17. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
________________________________________________
2. Gusberg SB. Estrogen and endometrial cancer: an epilogue la recherche du temps perdu. Gynecol Oncol 1994; 52: 3–9.
3. Haoula Z, Salman M, Atiomo W. Evaluating the association between endometrial cancer and polycystic ovary syndrome. Hum Reprod 2012; 27: 1327–31.
4. Gottschau M et al. Risk of cancer among women with polycystic ovary syndrome. Gynecol Oncol 2015; 136: 99–103.
5. Gregory CW et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clinl Endocrinol Metab 2002; 87 (6): 2960–6.
6. Maliqueo M et al. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome. Fertil Steril 2003; 80 (2): 812–9.
7. Quezada S et al. Evalution of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometrial from untreated women with polycystic ovary syndrome. Fertil Steril 2006; 85 (4): 1017–26.
8. Villavicencio A et al. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovary syndrome with and without endometrial hyperplasia. Gynecol Obstet 2006; 103 (1): 307–14.
9. Avellaira C et al. Expression of molecules associated with tissue homeostasis in secretory endometrial from untreated women with polycystic ovary syndrome. Hum Reprod 2006; 21 (12): 311–21.
10. Chen Y et al. Expression of apoptosis regulatoryprotein bcl-2 and bax in endometrium of polycystic ovary syndrome. Chinese J Obstet Gynecol 1999; 34 (11): 652–4.
11. Xin Li et al. Endometrial progesterone resistance and PCOS. J Biomed Sci 2014; 21 (1): 2.
12. Zavalishina L.E., Frank G.A., Andreeva Iu.Iu. Utochniaiushchaia diagnostika pri rakakh nekotorykh lokalizatsii s ispol'zovaniem immunogistokhimicheskikh markerov. Praktich. posobie. M., 2006. [in Russian]
13. Kiselev V.I., Liasheko A.A. Molekuliarnye mekhanizmy reguliatsii giperplasticheskikh protsessov. M.: Dimitreid Grafik Grupp, 2005. [in Russian]
14. Pal'tsev M.A., Ivanov A.A. Mezhkletochnye vzaimodeistviia. M.: Meditsina, 1995. [in Russian]
15. Biokhimicheskie osnovy patologicheskikh protsessov. Pod red. E.S.Severina. M.: Meditsina, 2000. [in Russian]
16. Tabakman Iu.Iu. Rak endometriia. Rukovodstvo dlia vrachei. M.: Prakticheskaia meditsina, 2009. [in Russian]
17. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006.
Авторы
Е.В.Мусина*, Т.Г.Траль, М.А.Тарасова
ФГБНУ НИИ акушерства, гинекологии и репродуктологии им. Д.О.Отта. 199034, Россия, Санкт-Петербург, Менделеевская линия, д. 3
*e.musina@mail.ru
D.O.Ott Research Institute of Obstetrics, Gynecology and Reproduction. 199034, Russian Federation, Saint Petersburg, Mendeleevskaia liniia, d. 3
*e.musina@mail.ru
ФГБНУ НИИ акушерства, гинекологии и репродуктологии им. Д.О.Отта. 199034, Россия, Санкт-Петербург, Менделеевская линия, д. 3
*e.musina@mail.ru
________________________________________________
D.O.Ott Research Institute of Obstetrics, Gynecology and Reproduction. 199034, Russian Federation, Saint Petersburg, Mendeleevskaia liniia, d. 3
*e.musina@mail.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.
